The development of technology of Fludeoxyglucose (18F) for injection, laboratory analysis methods

18F-Fluorodeoxyglucose has optimal characteristics for use in nuclear medicine and is a priority among radiopharmaceuticals for the diagnosis of cancer by positron emission tomography (PET). 18F-Fluorodeoxyglucose has the longest half-life with the lowest energy of radiation, it allows to obtain PET...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: V. V. Kachaniuk (Verfasst von), V. V. Trokhymchuk (Verfasst von), S. Y. Sarychev (Verfasst von)
Format: Buch
Veröffentlicht: The State Expert Center of the Ministry of Health of Ukraine, 2018-08-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Online

Connect to this object online.

3rd Floor Main Library

Bestandsangaben von 3rd Floor Main Library
Signatur: A1234.567
Exemplar 1 Verfügbar